Asset Management One Co. Ltd. Grows Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)

Asset Management One Co. Ltd. is a financial services company that provides investment management and advisory services to clients around the world. The company has recently disclosed that it lifted its stake in shares of Exact Sciences Co. NASDAQEXAS by 3.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

Exact Sciences Co. is a medical research company that specializes in developing and commercializing diagnostic tests for cancer and other diseases. The company's flagship product is the Cologuard DNA Test, which is used to detect colorectal cancer at an early stage.

According to the SEC filing, Asset Management One Co. Ltd. owned 70,236 shares of Exact Sciences Co.'s stock after buying an additional 2,351 shares during the third quarter. This represents a total investment of approximately $4.8 million in the company.

The increase in stake reflects Asset Management One Co. Ltd.'s confidence in the growth potential of Exact Sciences Co. The company has been impressed by the company's strong financial performance and its ability to develop innovative products that have the potential to improve patient outcomes and reduce healthcare costs.

In addition to its investment in Exact Sciences Co., Asset Management One Co. Ltd. also provides advisory services to the company, including strategic planning and capital markets support. The company believes that its expertise and resources can help Exact Sciences Co. continue to grow and succeed in the competitive medical research industry.